Is methadone maintenance provided by private practitioners effective?;Wie effektiv sind Methadonbehandlungen in Privatpraxen?

Sozial- und Praventivmedizin

Volumn 49, Issue 4, 2004, Pages 276-280

  Stohler, Rudolf ^a,b   Nordt, Carlos ^a   Falcato, Luis ^a   Dürsteler MacFarland, Kenneth M ^a   Rössler, Wulf ^a  

^a UNIVERSITY HOSPITAL OF PSYCHIATRY   (Switzerland)

^b NONE   (Switzerland)

Author keywords

Case register analysis; Drug clinic; Methadon maintenance treatment; Private practice; Retention

Indexed keywords

METHADONE;

ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FINANCIAL MANAGEMENT; HUMAN; INSTITUTIONAL CARE; KAPLAN MEIER METHOD; MAINTENANCE THERAPY; MEDICAL PRACTICE; PRIVATE PRACTICE; PROFESSIONAL PRACTICE; REGISTER; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS;

ADULT; FEMALE; HEROIN DEPENDENCE; HUMANS; LONG-TERM CARE; MALE; METHADONE; NARCOTICS; PATIENT CARE TEAM; PRIVATE PRACTICE; PROGNOSIS; SWITZERLAND; TREATMENT OUTCOME;

EID: 4344659563     PISSN: 03038408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Belding MA, McLellan AT, Zanis DA, Incmikoski R (1998). Characterizing "nonresponsive" methadone patients. J Subst Abuse Treat 15: 485-92.
2. Cacciola JS, Alterman AI, Rutherford MJ, McKay JR, Mulvaney FD (2001). The relationship of psychiatric comorbidity to treatment outcomes in methadon maintained patients. Drug Alcohol Depend 61: 271-80.
3. Falcato, L, Stohler R, Dürsteler-Mac Farland KM, Eichenberger A, Eich D, Rössler W (2001). Closure of an open drug scene - a case register-based analysis of the impact on the demand for methadone maintenance treatment. Addiction 96: 623-8.
4. Farré M, Mas A, Torrens M, Moreno V, Cami J (2002). Retention rate and illicit opioid use during methadone maintenance interventions: a meta-analysis. Drug Alcohol Depend 65: 283-90.
5. Grant BF (1997). Barriers to alcoholism treatment: reasons for not seeking treatment in a general population sample. J Stud Alcohol 58: 365-71.
6. Gruer I, Wilson P, Scott R, et al. (2001). General practitioner centred scheme for treatment of opiate dependent drug injectors in Glasgow. BMJ 314: 1730-5.
7. Lewis D, Bellis M (2001). General practice or drug clinic for methadone maintenance? A controlled comparison of treatment outcomes. Int J Drug Policy 12: 81-9.
8. Liechti F, Falcato L, Stohler R, Eich D, Rössler W (1999). Methadon-Dosierung ein Jahr nach Behandlungsbeginn. Mitteilungen der Sozialpsychiatrischen Forschungsgruppe der PUK Zürich 5: 1-2.
9. Liechti F, Falcato L, Stohler R, Eich D, Rössler W (2002). Psychosoziale Charakteristika, Methadondosierung und Heroinkonsum in ambulaten Methadonbehandlungen: ein matched pairs-Design. Soz Praventiv Med 47: 44-7.
10. Miller NS, Sheppard LM, Colenda CC, Magen J (2001). Why physicians are unprepared to treat patients who have alcohol- and drug-related disorders. Acad Med 76: 410-8.
11. Rhoades HM, Creson B, Elk R, Schmitz J, Grabowski J (1998). Retention, HIV risk, and illicit drug use during treatment: methadone dose and visit frequency. Am J Public Health 88: 34-9.
12. Sees KL, Delucchi KL, Masson C, et al (2000). Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence. JAMA 283: 1303-10.
13. Speed S., Janikiewicz SMJ (2000). A comparison of levels of satisfaction of stable drug users treated in general practice and an outpatient (community based) drug treatment service. Health Soc Care Community 8: 436-42.
14. Strain EC, Bigelow GE, Liebson IA, Stitzer ML (1999). Moderate - vs high-dose methadone in the treatment of opioid dependence. JAMA 281: 1000-5.
15. Ward J, Hall W, Mattick R (1999). Role of maintenance treatment in opioid dependence. Lancet 353: 221-6.